DataPrudence

The submission contains significant red flags and unsupported claims. While the bioinformatics market is relevant, the claims that the solution is for 'everyone' and that 'most people have used my product' are blatantly false and contradict the highly specialized nature of the technology. Additionally, reporting an 'all time marketcap' in place of monthly revenue suggests a misunderstanding of metrics or an unverified token-based model. Due to the lack of genuine evidence and obvious exaggerations, the project receives a negative calibration score.